NanoRepro AG (FRA:NN6)
1.525
-0.025 (-1.61%)
Last updated: Dec 5, 2025, 10:57 AM CET
NanoRepro AG Company Description
NanoRepro AG engages in the development, manufacture, and distribution of rapid diagnostic tests and food supplements for home and professional use in Germany and internationally.
The company provides products in the areas of family planning and disease detection, as well as food intolerances, allergies, and infectious diseases.
It offers rapid diagnostic tests, such as family planning, and preventive healthcare line products. The company also develops and commercializes immunochromatographic lateral flow tests; and tests for hospitals and medical practices.
The company is headquartered in Marburg, Germany.
NanoRepro AG
| Country | Germany |
| Founded | 2006 |
| Industry | In Vitro and In Vivo Diagnostic Substances |
| Employees | 23 |
| CEO | Lisa Jungst |
Contact Details
Address: Untergasse 8 Marburg, 35037 Germany | |
| Phone | 49 6421 951449 |
| Website | nanorepro.com |
Stock Details
| Ticker Symbol | NN6 |
| Exchange | Frankfurt Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Lisa Jungst | Chief Executive Officer |
| Stefan Pieh | Chief Financial Officer |